MMedication Read More UK approves its second weight-loss pill while EU access lags – POLITICOAugust 11, 2026 However, with the arrival of the first GLP-1 pill Wegovy (semaglutide) from Danish competitor Novo Nordisk — which…
MMedication Read More Supreme Court takes suo motu cognisance of access to life-saving medicines – Deccan HeraldJuly 17, 2026 Supreme Court takes suo motu cognisance of access to life-saving medicines Deccan Herald57 Hearings And An Unanswered Call For…
MMedication Read More Colorado’s first-of-its-kind price cap on an Amgen drug blockedJuly 2, 2026 Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
HHealthcare Read More Capricor Therapeutics accuses Nippon Shinyaku of slow-walking Duchenne drugMay 9, 2026 Capricor Therapeutics accused Nippon Shinyaku and its U.S. subsidiary of failing to follow through on marketing plans for…
MMedication Read More How a 340B successor might arise from the drug price negotiationsMarch 19, 2026 The 340B drug discount program requires manufacturers to sell drugs to safety-net hospitals at deep discounts, so they…
MMedication Read More Consumer group presses U.S. to authorize generic GLP-1sFebruary 13, 2026 Public Citizen petitioned the Trump administration to use a federal law to authorize generic competitors for GLP-1 drugs…
HHealthcare Read More Johnson & Johnson, U.S. agree on drug discounts, new plantsJanuary 9, 2026 Key Terms tariffs regulatory Tariffs are taxes imposed by a government on goods…
MMedication Read More Mark Cuban tries to shake up biosimilar pricing with a version of J&J’s StelaraNovember 6, 2025 In its latest bid to shake up the prescription drug market, the Mark Cuban Cost Plus Drug Company…
MMedication Read More Launch prices for new drugs ‘significantly’ exceed inflation, analysis saysOctober 23, 2025 Amid intensifying angst over prescription drug prices, a new analysis found that the median net price for 154…
MMedication Read More Let the rulemaking begin: Why direct-to-consumer drug ads deserve a closer lookSeptember 14, 2025 Call it death by disclosure. After nearly 30 years in which prescription drug ads have become a fixture…
HHealthcare Read More US drug pricing shake-up threatens access to medicines in Europe – POLITICOAugust 20, 2025 For European drugmakers there are still many unknowns about how the MFN scheme — and overall tariffs on…